SciSparc Said On February 5, Received Written Notice From Dekel Pharmaceuticals For Termination Of The License Agreement Dated May 20, 2015; Scisparc SaidCompany Disagrees And Rejects Dekel's Allegations As Set Forth In The Notice
Portfolio Pulse from Charles Gross
SciSparc received a termination notice from Dekel Pharmaceuticals for their license agreement dated May 20, 2015. SciSparc disagrees and rejects Dekel's allegations as stated in the notice.
February 12, 2024 | 9:34 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
SciSparc received a termination notice from Dekel Pharmaceuticals regarding their 2015 license agreement, which SciSparc disputes.
The termination of a license agreement and subsequent legal dispute can lead to uncertainties regarding SciSparc's future revenue and operations. Investors may react negatively to the news due to potential financial and reputational risks involved.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100